emetine has been researched along with Pancreatic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andera, L; Han, Y; Kim, I; Kim, KW; Kinyua, AW; Park, S | 1 |
Granberg, D; Hassan, S; Larsson, DE; Larsson, R; Oberg, K | 1 |
2 other study(ies) available for emetine and Pancreatic Neoplasms
Article | Year |
---|---|
Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Emetine; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Pancreatic Neoplasms; RNA Interference; RNA, Small Interfering; Small Molecule Libraries; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines.
Topics: 2-Aminopurine; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoid Tumor; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Emetine; Humans; Naphthoquinones; Neuroendocrine Tumors; Pancreatic Neoplasms | 2009 |